Bioton S.A. | Balance Sheet

Fiscal year is January-December. All values PLN Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
28
34
33
89
39
8
Total Accounts Receivable
141
186
136
75
99
58
Inventories
65
89
106
117
105
78
Other Current Assets
9
8
31
85
9
7
Total Current Assets
243
318
306
365
252
151
Net Property, Plant & Equipment
462
408
381
344
342
336
Total Investments and Advances
-
-
-
-
-
-
Long-Term Note Receivable
-
-
-
-
-
88
Intangible Assets
1,120
1,164
481
494
477
405
Other Assets
42
38
55
59
49
1
Total Assets
1,891
1,954
1,268
1,317
1,181
1,028
ST Debt & Current Portion LT Debt
114
104
161
182
175
Accounts Payable
70
83
83
62
39
Income Tax Payable
9
15
4
3
2
Other Current Liabilities
39
36
28
95
43
Total Current Liabilities
233
238
276
343
259
Long-Term Debt
112
98
65
48
23
Provision for Risks & Charges
9
10
9
4
4
Deferred Taxes
79
86
33
23
29
Other Liabilities
27
29
11
11
11
Total Liabilities
483
486
441
483
387
Common Equity (Total)
1,299
1,361
823
831
789
Total Shareholders' Equity
1,299
1,361
823
831
789
Total Equity
1,385
1,446
807
814
773
Liabilities & Shareholders' Equity
1,891
1,954
1,268
1,317
1,181
Accumulated Minority Interest
86
85
17
17
16
Non-Equity Reserves
23
22
21
20
20

About Bioton

View Profile
Address
Macierzysz, ul. Poznanska 12
Warsaw MZ 05
Poland
Employees -
Website http://www.bioton.pl
Updated 07/08/2019
BIOTON SA engages in the manufacture and production of medicines and pharmaceutical substances. The company offers oral hypoglycemic drug, foot cream and human insulin. It operates through the following segment: BIOTON S.